These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 21468253

  • 1. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute paraquat intoxication.
    Seok SJ, Kim SJ, Gil HW, Yang JO, Lee EY, Hong SY.
    J Korean Med Sci; 2011 Apr; 26(4):474-81. PubMed ID: 21468253
    [Abstract] [Full Text] [Related]

  • 2. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A, Lindoff C, Norrving B, Astedt B, Johansson BB.
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [Abstract] [Full Text] [Related]

  • 3. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
    Johansson L, Jansson JH, Boman K, Nilsson TK, Stegmayr B, Hallmans G.
    Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
    [Abstract] [Full Text] [Related]

  • 4. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study.
    Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, deFaire U.
    Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):2019-23. PubMed ID: 10938026
    [Abstract] [Full Text] [Related]

  • 5. Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients.
    Zuo Y, Warnock M, Harbaugh A, Yalavarthi S, Gockman K, Zuo M, Madison JA, Knight JS, Kanthi Y, Lawrence DA.
    Sci Rep; 2021 Jan 15; 11(1):1580. PubMed ID: 33452298
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
    Segarra A, Chacón P, Martinez-Eyarre C, Argelaguer X, Vila J, Ruiz P, Fort J, Bartolomé J, Camps J, Moliner E, Pelegrí A, Marco F, Olmos A, Piera L.
    J Am Soc Nephrol; 2001 Jun 15; 12(6):1255-1263. PubMed ID: 11373350
    [Abstract] [Full Text] [Related]

  • 7. Tissue plasminogen activator plasma levels as a potential diagnostic aid in acute pulmonary embolism.
    Flores J, García-Avello A, Flores VM, Navarro JL, Canseco F, Pérez-Rodríguez E.
    Arch Pathol Lab Med; 2003 Mar 15; 127(3):310-5. PubMed ID: 12653574
    [Abstract] [Full Text] [Related]

  • 8. Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects.
    Al-Hamodi Z, Ismail IS, Saif-Ali R, Ahmed KA, Muniandy S.
    Cardiovasc Diabetol; 2011 Mar 18; 10():23. PubMed ID: 21414238
    [Abstract] [Full Text] [Related]

  • 9. Lipoprotein(a), tissue plasminogen activator and plasminogen activator inhibitor 1 levels in hyperlipidaemic patients in Kuwait.
    Akanji AO, Abdullah A, Tahzeeb S.
    Eur J Clin Invest; 1997 May 18; 27(5):380-6. PubMed ID: 9179544
    [Abstract] [Full Text] [Related]

  • 10. Fibrinolytic Dysregulation in Total Joint Arthroplasty Patients: Potential Clinical Implications.
    Guler N, Burleson A, Syed D, Banos A, Hopkinson W, Hoppensteadt D, Rees H, Fareed J.
    Clin Appl Thromb Hemost; 2016 May 18; 22(4):372-6. PubMed ID: 26207021
    [Abstract] [Full Text] [Related]

  • 11. Plasma level of malondialdehyde in the cases of acute paraquat intoxication.
    Gil HW, Seok SJ, Jeong DS, Yang JO, Lee EY, Hong SY.
    Clin Toxicol (Phila); 2010 Feb 18; 48(2):149-52. PubMed ID: 20050821
    [Abstract] [Full Text] [Related]

  • 12. Tissue plasminogen activator and plasminogen activator inhibitor in patients with acute ischemic stroke: relation to stroke etiology.
    Zunker P, Schick A, Padró T, Kienast J, Phillips A, Ringelstein EB.
    Neurol Res; 1999 Dec 18; 21(8):727-32. PubMed ID: 10596380
    [Abstract] [Full Text] [Related]

  • 13. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
    Hevey D, McGee HM, Fitzgerald D, Horgan JH.
    Eur J Appl Physiol; 2000 Nov 18; 83(4 -5):344-8. PubMed ID: 11138573
    [Abstract] [Full Text] [Related]

  • 14. Role of tissue plasminogen activator and plasminogen activator inhibitor as potential biomarkers in psychosis.
    Elmi S, Sahu G, Malavade K, Jacob T.
    Asian J Psychiatr; 2019 Jun 18; 43():105-110. PubMed ID: 31125952
    [Abstract] [Full Text] [Related]

  • 15. Plasma levels of total plasminogen activator inhibitor-I (PAI-I) and tPA/PAI-1 complex in patients with disseminated intravascular coagulation and thrombotic thrombocytopenic purpura.
    Watanabe R, Wada H, Miura Y, Murata Y, Watanabe Y, Sakakura M, Okugawa Y, Nakasaki T, Mori Y, Nishikawa M, Gabazza EC, Shiku H, Nobori T.
    Clin Appl Thromb Hemost; 2001 Jul 18; 7(3):229-33. PubMed ID: 11441985
    [Abstract] [Full Text] [Related]

  • 16. [Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].
    Rabijewski M, Zgliczyński W.
    Endokrynol Pol; 2007 Jul 18; 58(3):213-9. PubMed ID: 17940987
    [Abstract] [Full Text] [Related]

  • 17. Comparison of plasminogen activator inhibitor-1, tissue type plasminogen activator antigen, fibrinogen, and D-dimer levels in various age decades in patients with type 2 diabetes mellitus and stable coronary artery disease (from the BARI 2D trial).
    McBane RD, Hardison RM, Sobel BE, BARI 2D Study Group.
    Am J Cardiol; 2010 Jan 01; 105(1):17-24. PubMed ID: 20102884
    [Abstract] [Full Text] [Related]

  • 18. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women.
    Svendsen OL, Hassager C, Christiansen C, Nielsen JD, Winther K.
    Arterioscler Thromb Vasc Biol; 1996 Mar 01; 16(3):381-5. PubMed ID: 8630663
    [Abstract] [Full Text] [Related]

  • 19. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F, Hasegawa N, Asano K, Sayama K, Fujita H, Urano T, Aoki T, Ishizaka A, Kanazawa M, Kawashiro T.
    Kokyu To Junkan; 1992 Jul 01; 40(7):685-90. PubMed ID: 1387724
    [Abstract] [Full Text] [Related]

  • 20. [Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system].
    Cao YJ, Wu YH, Liu CF.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2008 Jan 01; 36(1):62-7. PubMed ID: 19099932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.